The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Metabolic Syndrome and Sarcopenia
Open accessAbstract
Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S). Skeletal muscle loss and accumulation of intramuscular fat are associated with a variety of pathologies through a combination of factors, including oxidative stress, inflammatory cytokines, mitochondrial dysfunction, IR, and inactivity. Sarcopenia, defined by a loss of muscle mass and a decline in muscle quality and muscle function, is common in the elderly and is also often seen in patients with acute or chronic muscle-wasting diseases. The relationship between Met-S and sarcopenia has been attracting a great deal of attention these days. Persistent inflammation, fat deposition, and IR are thought to play a complex role in the association between Met-S and sarcopenia. Met-S and sarcopenia adversely affect QOL and contribute to increased frailty, weakness, dependence, and morbidity and mortality. Patients with Met-S and sarcopenia at the same time have a higher risk of several adverse health events than those with either Met-S or sarcopenia. Met-S can also be associated with sarcopenic obesity. In this review, the relationship between Met-S and sarcopenia will be outlined from the viewpoints of molecular mechanism and clinical impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Leong, D. P., Teo, K. K., Rangarajan, S., Lopez-Jaramillo, P., Avezum, A., Orlandini, A., Seron, P., Ahmed, S. H., Rosengren, A., Kelishadi, R., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62000-6 · Cited by 1,876
Loomba, R., & Sanyal, A. J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.171 · Cited by 1,641
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Cellular and molecular mechanisms of muscle atrophy
Bonaldo, P., & Sandri, M. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010389 · Cited by 1,284
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102 · cited 2×
“IR due to reduced skeletal muscle mass increases lipolysis, releases free fatty acids (FFAs) from adipose tissue, and inhibits the growth hormone (GH)-insulin like growth factor 1 (IGF1) axis, which promotes skeletal muscle protein synthesis [7].”
BackgroundYounossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Hamaguchi, M., Kojima, T., Takeda, N., Nakagawa, T., Taniguchi, H., Fujii, K., Omatsu, T., Nakajima, T., Sarui, H., Shimazaki, M., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-10-200511150-00009 · Cited by 1,062
Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 1×
“A positive correlation between sarcopenia and obesity is pointed out [62].”
BackgroundPredictors of skeletal muscle mass in elderly men and women
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00130-4 · Cited by 809 · cited 2×
“Sarcopenic obesity is defined as a condition involving a decrease in skeletal muscle mass, muscle weakness, and an increase in visceral adipose tissue, which simultaneously meets the following conditions: (1) muscle mass less than or equal to two standard deviations of the mean for young adults and (2) a body fat perc…”
BackgroundZisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1×
“In mice, muscle-specific knockout of GLUT4 results in severe IR and glucose intolerance [22].”
BackgroundNishikawa, H., Shiraki, M., Hiramatsu, A., Moriya, K., Hino, K., & Nishiguchi, S. (2016) · Hepatology Research · doi:10.1111/hepr.12774 · Cited by 656
Self-citationIL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2310 · Cited by 585
JSG-NAFLD, Eguchi, Y., Hyogo, H., Ono, M., Mizuta, T., Ono, N., Fujimoto, K., Chayama, K., & Saibara, T. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0533-z · Cited by 551
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440 · cited 7×
“Sarcopenia is also a risk for liver fibrosis development in NASH [85,86].”
BackgroundInfluentialDalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0034-6 · Cited by 403
Kim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401 · cited 1×
“However, for reasons such as differences in body size among races, there is no consensus on the calculation method, and the reference values vary [65,66].”
BackgroundVitamin D Deficiency and Sarcopenia in Older Persons
Remelli, F., Vitali, A., Zurlo, A., & Volpato, S. (2019) · Nutrients · doi:10.3390/nu11122861 · Cited by 348
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
Aleixo, G. F. P., Shachar, S. S., Nyrop, K. A., Muss, H. B., Malpica, L., & Williams, G. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102839 · Cited by 345
Almind, K., Manieri, M., Sivitz, W. I., Cinti, S., & Kahn, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610416104 · Cited by 286
Drummond, M. J., & Rasmussen, B. B. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282fa17fb · Cited by 274
The adipocyte as an endocrine organ in the regulation of metabolic homeostasis
Harwood, H. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.010 · Cited by 273
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
Eliades, M., Spyrou, E., Agrawal, N., Lazo, M., Brancati, F. L., Potter, J. J., Koteish, A. A., Clark, J. M., Guallar, E., & Hernaez, R. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12377 · Cited by 273
Walsh, M. C., Hunter, G. R., & Livingstone, M. B. (2006) · Osteoporosis International · doi:10.1007/s00198-005-1900-x · Cited by 268
Link between Metabolic Syndrome and Insulin Resistance
Gluvic, Z., Zaric, B., Resanovic, I., Obradovic, M., Mitrovic, A., Radak, D., & Isenovic, E. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666161007164510 · Cited by 259
(2015) · Nutritional Biochemistry · doi:10.1201/b18536-15 · Cited by 255
Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin
Kong, X., Yao, T., Zhou, P., Kazak, L., Tenen, D., Lyubetskaya, A., Dawes, B. A., Tsai, L., Kahn, B. B., Spiegelman, B. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.004 · Cited by 226
Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES
Son, J. W., Lee, S. S., Kim, S. R., Yoo, S. J., Cha, B. Y., Son, H. Y., & Cho, N. H. (2017) · Diabetologia · doi:10.1007/s00125-016-4196-9 · Cited by 222
Kitamoto, T., Kitamoto, A., Yoneda, M., Hyogo, H., Ochi, H., Nakamura, T., Teranishi, H., Mizusawa, S., Ueno, T., Chayama, K., et al. (2013) · Human Genetics · doi:10.1007/s00439-013-1294-3 · Cited by 212
Clinical detection of sarcopenic obesity by bioelectrical impedance analysis
Heber, D., Ingles, S., Ashley, J., Maxwell, M., Lyons, R., & Elashoff, R. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.3.472s · Cited by 198 · cited 1×
“This concept was first proposed in the work of Heber and colleagues [63], but a clearer definition was not developed until several years later.”
BackgroundSarcopenic obesity is closely associated with metabolic syndrome
Lu, C.-W., Yang, K.-C., Chang, H.-H., Lee, L.-T., Chen, C.-Y., & Huang, K.-C. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.02.003 · Cited by 198
Kim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198
Obesity and type 2 diabetes in Japanese patients
Sone, H., Ito, H., Ohashi, Y., Akanuma, Y., & Yamada, N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12151-4 · Cited by 198
Human Adipocytes Induce Inflammation and Atrophy in Muscle Cells During Obesity
Pellegrinelli, V., Rouault, C., Rodriguez-Cuenca, S., Albert, V., Edom-Vovard, F., Vidal-Puig, A., Clément, K., Butler-Browne, G. S., & Lacasa, D. (2015) · Diabetes · doi:10.2337/db14-0796 · Cited by 197
Uchitomi, R., Oyabu, M., & Kamei, Y. (2020) · Nutrients · doi:10.3390/nu12103189 · Cited by 193
Inoue, M., Iso, H., Yamamoto, S., Kurahashi, N., Iwasaki, M., Sasazuki, S., & Tsugane, S. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.03.008 · Cited by 188
Zhang, H., Lin, S., Gao, T., Zhong, F., Cai, J., Sun, Y., & Ma, A. (2018) · Nutrients · doi:10.3390/nu10030364 · Cited by 188
The Cardiometabolic Syndrome and Sarcopenic Obesity in Older Persons
Dominguez, L. J., & Barbagallo, M. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06673.x · Cited by 185 · cited 1×
“Subjects with sarcopenic obesity have an increased risk of developing physical dysfunction compared to subjects with obesity or sarcopenia alone [64,67].”
BackgroundBaek, S. J., Nam, G. E., Han, K. D., Choi, S. W., Jung, S. W., Bok, A. R., Kim, Y. H., Lee, K. S., Han, B. D., & Kim, D. H. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0011-3 · Cited by 182
Crawford, J., Prado, C. M. M., Johnston, M. A., Gralla, R. J., Taylor, R. P., Hancock, M. L., & Dalton, J. T. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0522-0 · Cited by 178
Adipokines, Myokines and Cardiovascular Disease
Walsh, K. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0961 · Cited by 178
Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
Bączek, J., Silkiewicz, M., & Wojszel, Z. B. (2020) · Nutrients · doi:10.3390/nu12082401 · Cited by 178
Yoon, J. W., Ha, Y., Kim, K. M., Moon, J. H., Choi, S. H., Lim, S. K., Park, Y. J., Lim, J., Kim, K. W., Park, K. S., et al. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.140 · Cited by 170
Sugimoto, K., Tabara, Y., Ikegami, H., Takata, Y., Kamide, K., Ikezoe, T., Kiyoshige, E., Makutani, Y., Onuma, H., Gondo, Y., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13070 · Cited by 166
Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
Vitamin D receptor(s): In the nucleus but also at membranes?
Zmijewski, M. A., & Carlberg, C. (2020) · Experimental Dermatology · doi:10.1111/exd.14147 · Cited by 162
Han, K., Park, Y.-M., Kwon, H.-S., Ko, S.-H., Lee, S.-H., Yim, H. W., Lee, W.-C., Park, Y. G., Kim, M. K., & Park, Y.-M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086902 · Cited by 158
Asano, L., Watanabe, M., Ryoden, Y., Usuda, K., Yamaguchi, T., Khambu, B., Takashima, M., Sato, S., Sakai, J., Nagasawa, K., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2016.12.017 · Cited by 157
Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
Barbalho, S. M., Flato, U. A. P., Tofano, R. J., Goulart, R. D. A., Guiguer, E. L., Detregiachi, C. R. P., Buchaim, D. V., Araújo, A. C., Buchaim, R. L., Reina, F. T. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103607 · Cited by 156 · cited 1×
“associated with muscle fiber proliferation) and IGF-1, which have muscle-protein-synthesispromoting effects, and conversely decreases myostatin, which has muscle-protein-synthesisinhibiting effects [95].”
BackgroundConsitt, L. A., & Clark, B. C. (2018) · The Journal of Frailty & Aging · doi:10.14283/jfa.2017.33 · Cited by 122
Muscle wasting disease: a proposal for a new disease classification
Anker, S. D., Coats, A. J. S., Morley, J. E., Rosano, G. M. C., Bernabei, R., von Haehling, S., & Kalantar‐Zadeh, K. (2014) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-014-0135-0 · Cited by 118
Ishii, S., Tanaka, T., Akishita, M., Ouchi, Y., Tuji, T., Iijima, K., & for the Kashiwa study investigators (2014) · PLoS ONE · doi:10.1371/journal.pone.0112718 · Cited by 112
Estrogen replacement and skeletal muscle: mechanisms and population health
Tiidus, P. M., Lowe, D. A., & Brown, M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00629.2013 · Cited by 111
Vitamin D Receptor Polymorphisms and Cancer
Gandini, S., Gnagnarella, P., Serrano, D., Pasquali, E., & Raimondi, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0437-2_5 · Cited by 104
Kim, G., Lee, S., Jun, J. E., Lee, Y., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0659-2 · Cited by 104
Yu, R., Shi, Q., Liu, L., & Chen, L. (2018) · BMC Gastroenterology · doi:10.1186/s12876-018-0776-0 · Cited by 102
The Role of Exercise, Diet, and Cytokines in Preventing Obesity and Improving Adipose Tissue
ATAKAN, M. M., Koşar, Ş. N., Güzel, Y., Tin, H. T., & Yan, X. (2021) · Nutrients · doi:10.3390/nu13051459 · Cited by 99
Association between sarcopenia level and metabolic syndrome
Kim, S. H., Jeong, J. B., Kang, J., Ahn, D., Kim, J. W., Kim, B. G., Lee, K. L., Oh, S., Yoon, S. H., Park, S. J., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248856 · Cited by 97
Muscle mass, survival, and the elderly ICU patient
Griffiths, R. (1996) · Nutrition · doi:10.1016/s0899-9007(96)00141-4 · Cited by 95
Association of C-reactive protein and muscle strength in the English Longitudinal Study of Ageing
Hamer, M., & Molloy, G. J. (2009) · AGE · doi:10.1007/s11357-009-9097-0 · Cited by 93
Koda, M., Kawakami, M., Murawaki, Y., & Senda, M. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2107-z · Cited by 87
Oh, C., Jho, S., No, J.-K., & Kim, H. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.07.018 · Cited by 82
Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
Wijarnpreecha, K., Panjawatanan, P., Thongprayoon, C., Jaruvongvanich, V., & Ungprasert, P. (2018) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_237_17 · Cited by 80
The role of muscle mass and body fat on disability among older adults: A cross-national analysis
Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso‐Mateos, J. L., Miret, M., Chatterji, S., Tobiasz‐Adamczyk, B., Koskinen, S. V. P., Leonardi, M., & Haro, J. M. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.002 · Cited by 78
Wu, H., Liu, M., Quynh, V. T., Wang, J., Zhang, Q., Liu, L., Meng, G., Yao, Z., Bao, X., Gu, Y., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.01.011 · Cited by 69
Vitamin D Receptor Polymorphisms and Cancer
Gnagnarella, P., Raimondi, S., Aristarco, V., Johansson, H. A., Bellerba, F., Corso, F., & Gandini, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_4 · Cited by 69
Adverse effects of coexistence of sarcopenia and metabolic syndrome in Japanese women
Sanada, K., Iemitsu, M., Murakami, H., Gando, Y., Kawano, H., Kawakami, R., Tabata, I., & Miyachi, M. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.43 · Cited by 68
Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia
Dong, M., Lin, J., Lim, W., Jin, W., & Lee, H. J. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0555-2 · Cited by 63
Hajhashemy, Z., Shahdadian, F., Moslemi, E., Mirenayat, F. S., & Saneei, P. (2021) · Obesity Reviews · doi:10.1111/obr.13223 · Cited by 61
Pan, X., Han, Y., Zou, T., Zhu, G., Xu, K., Zheng, J.-N., Zheng, M., & Cheng, X. (2018) · Digestive Diseases · doi:10.1159/000491015 · Cited by 58
for the ERA JUMP Study Group, Ahuja, V., Kadowaki, T., Evans, R. G., Kadota, A., Okamura, T., Khoudary, S. R. E., Fujiyoshi, A., Barinas‐Mitchell, E., Hisamatsu, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3414-6 · Cited by 52
Mukai, N., Doi, Y., Ninomiya, T., Hata, J., Yonemoto, K., Iwase, M., Iida, M., & Kiyohara, Y. (2009) · Diabetes Care · doi:10.2337/dc09-0896 · Cited by 51
Park, S., Ryu, S. Y., Park, J., & Choi, S.-W. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0059 · Cited by 51
Effects of physical exercise in sarcopenia. A systematic review
Galindo, D. E. B., Arnáiz, E. G., Vicente, P. F., & Ballesteros-Pomar, M. D. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.02.007 · Cited by 51
Alexandre, T. D. S., Aubertin‐Leheudre, M., Carvalho, L. P., Máximo, R. D. O., Corona, L. P., de Brito, T. R. P., Nunes, D. P., Santos, J. L. F., Duarte, Y. A. D. O., & Lebrão, M. L. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.009 · Cited by 50
Meng, G., Wu, H., Fang, L., Li, C., Yu, F., Zhang, Q., Liu, L., Du, H., Shi, H., Xia, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep33255 · Cited by 49
Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
Chong, M. S., Lim, J. P., Leung, B., Ding, Y. Y., Tay, L., Ismail, N. H., Yeo, A., & Yew, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s78901 · Cited by 43 · cited 1×
“Proinflammatory cytokines such as TNF-α, monocyte chemoattractant protein-1 (MCP-1), IL-6, and CRP, which affect IR, are produced by adipose tissue, and muscle protein synthesis is reduced, inducing Met-S and sarcopenic obesity [35].”
BackgroundPérez, E. A., Olivares, V. M., Martínez‐Espinosa, R. M., Vila, M. D. M., & García-Galbis, M. R. (2018) · Nutrients · doi:10.3390/nu10070878 · Cited by 40
Churilla, J. R., Summerlin, M., Richardson, M. R., & Boltz, A. J. (2020) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003515 · Cited by 39
Tabrizi, R., Hallajzadeh, J., Mirhosseini, N. Z., Lankarani, K. B., Maharlouei, N., Akbari, M., & Asemi, Z. (2019) · EXCLI journal · doi:10.17179/excli2019-1386 · Cited by 37
Park, S. H., Kim, D. J., & Plank, L. D. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0591-x · Cited by 36
Zhou, L., Xu, L., Wang, X.-Q., Huang, Y., & Xiao, Q. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0288-3 · Cited by 35
Akter, S., Eguchi, M., Kurotani, K., Kochi, T., Kashino, I., Ito, R., Kuwahara, K., Tsuruoka, H., Kabe, I., & Mizoue, T. (2016) · Nutrition · doi:10.1016/j.nut.2016.02.024 · Cited by 35
Efectos del ejercicio físico en el anciano con sarcopenia. Una revisión sistemática
Galindo, D. E. B., Arnáiz, E. G., Vicente, P. F., & Ballesteros-Pomar, M. D. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.02.010 · Cited by 30
Shen, C., Lu, J., Xu, Z., Xu, Y., & Yang, Y. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041384 · Cited by 28
Tamura, Y. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0435 · Cited by 26
Sarcopenia and nonalcoholic fatty liver disease: a causal relationship
Pacifico, L., Perla, F. M., & Chiesa, C. (2019) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.11.11 · Cited by 24
Pang, Q., Qu, K., Liu, C., Zhang, J., & Liu, S. (2015) · Hepatology · doi:10.1002/hep.28010 · Cited by 15
Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
Habig, G., Smaltz, C. M., & Halegoua-DeMarzio, D. L. (2021) · Metabolites · doi:10.3390/metabo11040242 · Cited by 13
Wu, S., & Chen, W. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14607 · Cited by 8
Cited by
Schmidt, P. H. S., Pasqualotto, E., dos Santos, H. V., de Souza, L. S. N., dos Santos, B. E., Chavez, M. P., Ferreira, R. O. M., Hohl, A., Ronsoni, M. F., & van de Sande-Lee, S. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.01.009 · Cited by 18
Metadata
- Authors
- Nishikawa, H., Asai, A., Fukunishi, S., Nishiguchi, S., & Higuchi, K.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-10-07
- Volume
- 13
- Issue
- 10
- Pages
- 3519
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W3206959502
- Cited by
- 321
- References
- 107
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.